Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 143

1.

Risk perception in MSM taking prep: a survey.

Whitlock G, Boccino S, Kanagalinghan U, Nwokolo N.

Sex Transm Infect. 2017 Aug;93(5):325. doi: 10.1136/sextrans-2016-053050. Epub 2017 Jul 20. No abstract available.

PMID:
28729517
2.

High HIV incidence in men who have sex with men following an early syphilis diagnosis: is there room for pre-exposure prophylaxis as a prevention strategy?

Girometti N, Gutierrez A, Nwokolo N, McOwan A, Whitlock G.

Sex Transm Infect. 2017 Aug;93(5):320-322. doi: 10.1136/sextrans-2016-052865. Epub 2016 Oct 19.

PMID:
28729516
3.

InterPrEP: internet-based pre-exposure prophylaxis with generic tenofovir disoproxil fumarate/emtrictabine in London - analysis of pharmacokinetics, safety and outcomes.

Wang X, Nwokolo N, Korologou-Linden R, Hill A, Whitlock G, Day-Weber I, McClure MO, Boffito M.

HIV Med. 2017 Jun 28. doi: 10.1111/hiv.12528. [Epub ahead of print]

PMID:
28657199
4.

Reasons for transferring HIV care in London.

Ahmed N, Scott D, Matin N, Waters L, Whitlock G.

Int J STD AIDS. 2017 Jan 1:956462417708729. doi: 10.1177/0956462417708729. [Epub ahead of print]

PMID:
28509659
5.

2016 RAD-AID Conference on International Radiology for Developing Countries: Gaps, Growth, and United Nations Sustainable Development Goals.

Mollura DJ, Soroosh G, Culp MP; RAD-AID Conference Writing Group.

J Am Coll Radiol. 2017 Jun;14(6):841-847. doi: 10.1016/j.jacr.2017.01.049. Epub 2017 Mar 31.

PMID:
28372963
6.

Not just PrEP: other reasons for London's HIV decline.

Nwokolo N, Whitlock G, McOwan A.

Lancet HIV. 2017 Apr;4(4):e153. doi: 10.1016/S2352-3018(17)30044-9. No abstract available.

PMID:
28359449
7.

Design and Synthesis of a Pan-Janus Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin.

Jones P, Storer RI, Sabnis YA, Wakenhut FM, Whitlock GA, England KS, Mukaiyama T, Dehnhardt CM, Coe JW, Kortum SW, Chrencik JE, Brown DG, Jones RM, Murphy JR, Yeoh T, Morgan P, Kilty I.

J Med Chem. 2017 Jan 26;60(2):767-786. doi: 10.1021/acs.jmedchem.6b01634. Epub 2017 Jan 4.

PMID:
27983835
8.

Diabetes and Cause-Specific Mortality in Mexico City.

Alegre-Díaz J, Herrington W, López-Cervantes M, Gnatiuc L, Ramirez R, Hill M, Baigent C, McCarthy MI, Lewington S, Collins R, Whitlock G, Tapia-Conyer R, Peto R, Kuri-Morales P, Emberson JR.

N Engl J Med. 2016 Nov 17;375(20):1961-1971. doi: 10.1056/NEJMoa1605368.

9.

Quantitative Chemical Proteomic Profiling of Ubiquitin Specific Proteases in Intact Cancer Cells.

Ward JA, McLellan L, Stockley M, Gibson KR, Whitlock GA, Knights C, Harrigan JA, Jacq X, Tate EW.

ACS Chem Biol. 2016 Dec 16;11(12):3268-3272. Epub 2016 Oct 31.

10.

Outcomes of acutely HIV-1-infected individuals following rapid antiretroviral therapy initiation.

Girometti N, Nwokolo N, McOwan A, Whitlock G.

Antivir Ther. 2017;22(1):77-80. doi: 10.3851/IMP3080. Epub 2016 Sep 2.

PMID:
27585954
11.

High HIV incidence in men who have sex with men attending for postexposure prophylaxis: a service evaluation.

Whitlock G, McCormack C, Fearnley J, McOwan A.

Sex Transm Infect. 2017 May;93(3):214-216. doi: 10.1136/sextrans-2016-052623. Epub 2016 Jul 13.

PMID:
27412954
12.

Assessing risk among MSM: service evaluation demonstrates feasibility of a single-question approach.

Hennigan O, Whitlock G.

Sex Transm Infect. 2016 Jun;92(4):265. doi: 10.1136/sextrans-2015-052505. No abstract available.

PMID:
27199485
13.

Novel Amino-pyrazole Ureas with Potent In Vitro and In Vivo Antileishmanial Activity.

Mowbray CE, Braillard S, Speed W, Glossop PA, Whitlock GA, Gibson KR, Mills JE, Brown AD, Gardner JM, Cao Y, Hua W, Morgans GL, Feijens PB, Matheeussen A, Maes LJ.

J Med Chem. 2015 Dec 24;58(24):9615-24. doi: 10.1021/acs.jmedchem.5b01456. Epub 2015 Dec 4.

PMID:
26571076
14.

Is PEP prescribed appropriately?

Whitlock G, Nwokolo N, McOwan A.

HIV Med. 2015 Sep;16(8):519-20. doi: 10.1111/hiv.12275.

PMID:
26245890
15.

Distinct Urban Mines: Exploiting secondary resources in unique anthropogenic spaces.

Ongondo FO, Williams ID, Whitlock G.

Waste Manag. 2015 Nov;45:4-9. doi: 10.1016/j.wasman.2015.05.026. Epub 2015 Jun 9.

PMID:
26066575
16.

HIV integrase inhibitors: a new era in the treatment of HIV.

Blanco JL, Whitlock G, Milinkovic A, Moyle G.

Expert Opin Pharmacother. 2015 Jun;16(9):1313-24. doi: 10.1517/14656566.2015.1044436. Review.

PMID:
26001181
17.

Small-molecule anti-inflammatory drug compositions for the treatment of asthma: a patent review (2013 - 2014).

Glossop P, Whitlock G, Gibson K.

Expert Opin Ther Pat. 2015 Jul;25(7):743-54. doi: 10.1517/13543776.2015.1041923. Epub 2015 May 14. Review.

PMID:
25972122
18.

Socioeconomic status in relation to cardiovascular disease and cause-specific mortality: a comparison of Asian and Australasian populations in a pooled analysis.

Woodward M, Peters SA, Batty GD, Ueshima H, Woo J, Giles GG, Barzi F, Ho SC, Huxley RR, Arima H, Fang X, Dobson A, Lam TH, Vathesatogkit P; Asia Pacific Cohort Studies Collaboration.

BMJ Open. 2015 Mar 17;5(3):e006408. doi: 10.1136/bmjopen-2014-006408.

19.

Does dropping day 5 PEP follow-up affect outcomes? An audit of HIV post-exposure prophylaxis at a central London sexual health clinic.

O'Keeffe C, Nwokolo N, McOwan A, Whitlock G.

Int J STD AIDS. 2015 Jul;26(8):590-2. doi: 10.1177/0956462414547090. Epub 2014 Aug 12.

PMID:
25122580
20.

Diagnostics within the clinic to test for gonorrhoea and chlamydia reduces the time to treatment: a service evaluation.

Wingrove I, McOwan A, Nwokolo N, Whitlock G.

Sex Transm Infect. 2014 Sep;90(6):474. doi: 10.1136/sextrans-2014-051580. No abstract available.

PMID:
25118322

Supplemental Content

Loading ...
Support Center